Fast Track Laparoscopic Surgery: A Better Option for Treating Colorectal Cancer Than Conventional Laparoscopic Surgery (FTS)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≤75 years
- Good nutrition
- no systemic infection
- Elective laparoscopic surgery
Exclusion Criteria:
- Age >75 years
- Malnutrition or an organ system infection
- Associated with obstruction, bleeding, emergency surgery or surgical intervention
- Tumor with extensive metastasis
- Before operation patient was fasting, underwent gastrointestinal decompression and received nutritional support
- Previous history of abdominal surgery
- Patient had previously undergone gastrostomy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: fast-track surgery
Patients with colorectal cancer will undergo laparoscopic colorectal resection, and will be divided into two groups.
Protocols for fast-track group includes skipping preoperative mechanical bowel preparation, early restoration of diet and early postoperative ambulation.
|
Patients with colorectal cancer will undergo laparoscopic colorectal resection, and will be divided into two groups.
Protocols for fast-track group includes skipping preoperative mechanical bowel preparation, early restoration of diet and early postoperative ambulation.
|
|
Other: convontional postoperative care
Patients with colorectal cancer will undergo laparoscopic colorectal resection, and will be divided into two groups.
Protocols for fast-track group includes skipping preoperative mechanical bowel preparation, early restoration of diet and early postoperative ambulation.
|
Patients with colorectal cancer will undergo laparoscopic colorectal resection, and will be divided into two groups.
Protocols for fast-track group includes skipping preoperative mechanical bowel preparation, early restoration of diet and early postoperative ambulation.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Length of hospital stay
Time Frame: with the first 30 days(plus or minus 3days) after surgery
|
with the first 30 days(plus or minus 3days) after surgery
|
|
Postoperative days
Time Frame: with the first 30 days(plus or minus 3days) after surgery
|
with the first 30 days(plus or minus 3days) after surgery
|
|
First flatus time
Time Frame: with the first 30 days(plus or minus 3days) after surgery
|
with the first 30 days(plus or minus 3days) after surgery
|
|
First defecation time
Time Frame: with the first 30 days(plus or minus 3days) after surgery
|
with the first 30 days(plus or minus 3days) after surgery
|
|
solid diet time
Time Frame: with the first 30 days(plus or minus 3days) after surgery
|
with the first 30 days(plus or minus 3days) after surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Analgesics
Time Frame: with the first 30 days(plus or minus 3days) after surgery
|
with the first 30 days(plus or minus 3days) after surgery
|
|
CRP (mg/L)
Time Frame: with the first 30 days(plus or minus 3days) after surgery
|
with the first 30 days(plus or minus 3days) after surgery
|
|
Complications:anastomotic leakage,intestinal obstruction,wound infection
Time Frame: one year
|
one year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2013-171 (Other Identifier: Barbara Ann Karmanos Cancer Institute)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.